孤独症谱系障碍患儿血清25(OH)D水平的检测

杜琳, 单玲, 王冰, 冯俊燕, 徐志达, 贾飞勇

中国当代儿科杂志 ›› 2015, Vol. 17 ›› Issue (1) : 68-71.

PDF(1324 KB)
HTML
PDF(1324 KB)
HTML
中国当代儿科杂志 ›› 2015, Vol. 17 ›› Issue (1) : 68-71. DOI: 10.7499/j.issn.1008-8830.2015.01.015
论著·临床研究

孤独症谱系障碍患儿血清25(OH)D水平的检测

  • 杜琳1, 单玲1, 王冰1, 冯俊燕1, 徐志达1,2, 贾飞勇1
作者信息 +

Serum levels of 25-hydroxyvitamin D in children with autism spectrum disorders

  • DU Lin1, SHAN Ling1, WANG Bing1, FENG Jun-Yan1, XU Zhi-Da1,2, JIA Fei-Yong1
Author information +
文章历史 +

摘要

目的 了解孤独症谱系障碍(ASD)患儿维生素D 营养状况,探讨维生素D 水平与ASD 的关系.方法 采用高效液相色谱- 串联质谱法对117 例新诊断的ASD 患儿和109 例健康对照儿童进行血清25(OH)D检测,并根据血清25(OH)D 水平,将维生素D 状况分为正常(>30 ng/mL)、不足(10~30 ng/mL)和缺乏(<10 ng/mL),比较两组儿童维生素D 营养状况.结果 ASD 患儿25(OH)D 水平(19±9 ng/mL)明显低于对照组(36±13 ng/mL), 差异有统计学意义(P<0.01). ASD 患儿中维生素D 缺乏和不足率为89.7%,明显高于对照组(52.3%),差异有统计学意义(P<0.01).结论 ASD 患儿存在维生素D 缺乏或不足,维生素D 缺乏和不足有可能是ASD 发病的环境/遗传因素.

Abstract

Objective To examine serum 25-hydroxyvitamin D levels in children with autism spectrum disorders (ASD) and to explore the relationship between vitamin D level and ASD. Methods Serum levels of 25-hydroxyvitamin D levels were determined by the HPLC-MS/MS method in 117 children with newly diagnosed ASD and 109 healthy controls. Vitamin D status were classified into normal (>30 ng/mL), insufficiency (10-30ng/mL) and deficiency (<10 ng/mL) according to 25-hydroxyvitamin D levels. Results Serum level of 25-hydroxyvitamin D (19±9 ng/mL) in children with ASD was significantly lower than that in healthy controls (36±13 ng/mL; P<0.01). The rate of vitamin D insufficiency plus deficiency in the ASD group was significantly higher than in the control group (89.7% vs 52.3%; P<0.01). Conclusions Vitamin D insufficiency or deficiency is common in children with ASD and might be as one of the environmental or genetic factors for ASD.

关键词

孤独症谱系障碍 / 维生素D / 环境因素 / 遗传因素 / 儿童

Key words

Autism spectrum disorders / Vitamin D / Environmental factor / Genetic factor / Child

引用本文

导出引用
杜琳, 单玲, 王冰, 冯俊燕, 徐志达, 贾飞勇. 孤独症谱系障碍患儿血清25(OH)D水平的检测[J]. 中国当代儿科杂志. 2015, 17(1): 68-71 https://doi.org/10.7499/j.issn.1008-8830.2015.01.015
DU Lin, SHAN Ling, WANG Bing, FENG Jun-Yan, XU Zhi-Da, JIA Fei-Yong. Serum levels of 25-hydroxyvitamin D in children with autism spectrum disorders[J]. Chinese Journal of Contemporary Pediatrics. 2015, 17(1): 68-71 https://doi.org/10.7499/j.issn.1008-8830.2015.01.015

参考文献

[1] Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal Investigators, Centers for Disease Control and Prevention (CDC). Prevalence of Autism Spectrum Disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008[J]. MMWR Surveillance Summaries, 2012, 61(SS03): 1-19.
[2] Kubota T, Takae H, Miyake K. Epigenetic mechanisms and therapeutic perspectives for neurodevelopmental disorders[J]. Pharmaceuticals (Basel), 2012, 5(4): 369-383.
[3] Autier P, Boniol M, Pizot C, et al. Vitamin D status and ill health: a systematic review[J]. Lancet Diabetes Endocrinol, 2014, 2(1): 76-89.
[4] Salami M, Talaei SA, Davari S, et al. Hippocampal long term potentiation in rats under different regimens of vitamin D: an in vivo study[J]. Neurosci Lett, 2012, 509(1): 56-59.
[5] Stoner R, Chow ML, Boyle MP, et al. Patches of disorganization in the neocortex of children with autism[J]. N Engl J Med, 2014, 370(13): 1209-1219.
[6] Zielinski BA, Prigge MB, Nielsen JA, et al. Longitudinal changes in cortical thickness in autism and typical development[J]. Brain, 2014, 137(Pt 6): 1799-17812.
[7] Cannell JJ, Grant WB. What is the role of vitamin D in autism?[J]. Dermatoendocrinol, 2013, 5(1): 199-204.
[8] Kim YS, Fombonne E, Koh YJ, et al. A comparison of DSM-IV pervasive developmental disorder and DSM-5 autism spectrum disorder prevalence in an epidemiologic sample[J]. J Am Acad Child Adolesc Psychiatry, 2014, 53(5): 500-508.
[9] Gallo S, Jean-Philippe S, Rodd C, et al. Vitamin D supplementation of Canadian infants: practices of Montreal mothers[J]. Appl Physiol Nutr Metab, 2010, 35(3): 303-309.
[10] Guthrie W, Swineford LB, Wetherby AM, et al. Comparison of DSM-IV and DSM-5 factor structure models for toddlers with autism spectrum disorder[J]. J Am Acad Child Adolesc Psychiatry, 2013, 52(8): 797-805.
[11] Tsai LY, Ghaziuddin M. DSM-5 ASD moves forward into the past[J]. J Autism Dev Disord, 2014, 44(2): 321-330.
[12] Morris HA. Vitamin D activities for health outcomes[J]. Ann Lab Med, 2014, 34(3): 181-186.
[13] Gröber U, Spitz J, Reichrath J, et al. Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcare[J]. Dermatoendocrinol, 2013, 5(3): 331-347.
[14] Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality— a review of recent evidence[J]. Autoimmun Rev, 2013,12(10): 976-989.
[15] Tsagari A, Toulis KA, Makras P, et al. Performance of the mini nutritional assessment score in the detection of vitamin D status in an elderly Greek population[J]. Horm Metab Res, 2012, 44(12): 896-899.
[16] Grant WB, Tangpricha V. Vitamin D: Its role in disease prevention[J]. Dermatoendocrinol, 2012, 4(2): 81-83.
[17] Farrell CJ, Martin S, McWhinney B, et al. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatography-tandem mass spectrometry methods[J]. Clin Chem, 2012, 58(3): 531-542.
[18] Mostafa GA, Al-Ayadhi LY. Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: relation to autoimmunity[J]. J Neuroinflammation, 2012, 9: 201.
[19] 胡有瑶, 张宁. 0-14 岁儿童25-羟维生素D 水平及其与季 节关系[J]. 临床儿科杂志,2014, 32(2): 194.
[20] 段小燕, 贾飞勇, 姜慧轶. 维生素D 与孤独症谱系障碍的关 系[J]. 中国当代儿科杂志, 2013, 15(8): 698-702.
[21] Whitehouse AJ, Holt BJ, Serralha M, et al. Maternal vitamin D levels and the autism phenotype among offspring[J]. J Autism Dev Disord, 2013,43(7): 1495-1504.
[22] Meador KJ, Loring DW. Risks of in utero exposure to valproate[J]. JAMA, 2013, 309(16): 1730-1731.
[23] Marques CD, Dantas AT, Fragoso TS, et al. The importance of vitamin D levels in autoimmune diseases[J]. Rev Bras Reumatol, 2010, 50(1): 67-80.
[24] Jiang P, Zhu MQ, Li HD, et al. Effects of vitamin D receptor polymorphisms on the risk of schizophrenia and metabolic changes caused by risperidone treatment[J]. Psychiatry Res, 2014, 215(3): 806-807.

PDF(1324 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/